Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Nix

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Infectious Disease Clinics of North America|October 21, 1998
Intrapulmonary concentrations of antimicrobial agentsD E Nix
Clinical Pharmacy|September 1, 1992
Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobialsW T Symonds, D E Nix
Clinical Pharmacokinetics|October 1, 1993
Cefpirome clinical pharmacokineticsL C Strenkoski, D E Nix
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibioticsD E Nix, J J Schentag
Clinical Pharmacy|November 1, 1988
Storing extra calibration curves in the TDx assay systemD E Nix, C A Peloquin
Journal of Clinical Pharmacology|February 1, 1988
The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamicsD E Nix, J J Schentag
Hospital Topics|March 1, 1977
"My hospital is different"D E Nix, R F Catalanello
Clinical Pharmacy|February 1, 1987
Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobialsD E Nix, J M DeVito
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalisD E Nix, R Tyrrell, M Müller
Antimicrobial Agents and Chemotherapy|July 1, 1989
Effect of lomefloxacin on theophylline pharmacokineticsD E Nix, A Norman, J J Schentag
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Infectious Disease Clinics of North America|October 21, 1998
Intrapulmonary concentrations of antimicrobial agentsD E Nix
Clinical Pharmacy|September 1, 1992
Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobialsW T Symonds, D E Nix
Clinical Pharmacokinetics|October 1, 1993
Cefpirome clinical pharmacokineticsL C Strenkoski, D E Nix
Diagnostic Microbiology and Infectious Disease|May 1, 1995
Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibioticsD E Nix, J J Schentag
Clinical Pharmacy|November 1, 1988
Storing extra calibration curves in the TDx assay systemD E Nix, C A Peloquin
Journal of Clinical Pharmacology|February 1, 1988
The quinolones: an overview and comparative appraisal of their pharmacokinetics and pharmacodynamicsD E Nix, J J Schentag
Hospital Topics|March 1, 1977
"My hospital is different"D E Nix, R F Catalanello
Clinical Pharmacy|February 1, 1987
Ciprofloxacin and norfloxacin, two fluoroquinolone antimicrobialsD E Nix, J M DeVito
Antimicrobial Agents and Chemotherapy|August 1, 1995
Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalisD E Nix, R Tyrrell, M Müller
Antimicrobial Agents and Chemotherapy|July 1, 1989
Effect of lomefloxacin on theophylline pharmacokineticsD E Nix, A Norman, J J Schentag
Pageof 8